Levels of fluconazole in normal and diseased nails during and after treatment of onychomycoses in toe-nails with fluconazole 150 mg once weekly

Acta Dermato-Venereologica

Volumn 76, Issue 3, 1996, Pages 219-221

  Faergemann, Jan ^a   Laufen, Heinrich ^b  

^a SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

^b PFIZER INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FLUCONAZOLE; GRISEOFULVIN; ITRACONAZOLE; TERBINAFINE;

ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG DISTRIBUTION; DRUG EFFICACY; DRUG TISSUE LEVEL; ONYCHOMYCOSIS; PRIORITY JOURNAL;

ANTIFUNGAL AGENTS; DOUBLE-BLIND METHOD; FLUCONAZOLE; GRISEOFULVIN; HUMANS; NAILS; ONYCHOMYCOSIS; TIME FACTORS;

EID: 0029890133     PISSN: 00015555     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (11)

1. Grant SM, Clissold SP. Fluconazole. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in superficial and systemic mycoses. Drugs 1990; 39: 877-916.
2. Bennett JE. Fluconazole: a novel advance in therapy for systemic fungal infections. Rev Infect Dis 1990; 12(Suppl 3): 263-390.
3. Haneke E. Pharmacokinetic evaluation of fluconazole in plasma, epidermis and blister fluid. Int J Dermatol 1992; 31 (Suppl 2): 3-5.
4. Hay RJ. Pharmacokinetic evaluation of fluconazole in skin and nails. Int J Dermatol 1992; 31 (Suppl 2): 6-7.
5. Faergemann J, Laufen H. Levels of fluconazole in serum, stratum corneum, epidermis-dermis (without stratum corneum) and eccrine sweat. Clin Exp Dermatol 1993; 18: 102-106.
6. Wood PR, Tarbit MH. Gas chromatographic method for the determination of fluconazole, a novel antifungal agent in human plasma and urine. J Chromatogr 1986; 383: 179.
7. Kuokkanen K, Alava S. Fluconazole in the treatment of onychomycosis caused by dermatophytes. J Dermato Treatm 1992; 3: 115-117.
8. Suchil P, Gei FM, Robles M, Perera-Ramirez A, Welsh O, Male O. Once-weekly oral doses of fluconazole 150 mg in the treatment of tinea corporis/cruris and cutaneous candidiasis. Clin Exp Dermatol 1992; 17: 397-401.
9. Del Aguila R, Gei FM, Robles M, Perera-Ramirez A, Male O. Once-weekly oral doses of fluconazole 150 mg in the treatment of tinea pedis. Clin Exp Dermatol 1992; 17:402-406.
10. Faergemann J, Zehender H, Denouël J, Millerioux L. Levels of terbinafine in plasma, stratum corneum, dermis-epidermis (without stratum corneum), sebum, hair and nails during and after 250 mg terbinafine orally once per day for four weeks. Acta Derm Venereol (Stockh) 1993; 73: 305-309.
11. Willemsen M, De Doncker P, Willems J, Woestenborghs R, Van de Velde V, Heykants J, et al. Posttreatment itraconazole levels in the nail. New implications for treatment in onychomycosis. J Am Acad Dermatol 1992; 26: 731-735.